Subtle Medical

Subtle Medical develops vendor-neutral software solutions that improve image quality on regular and accelerated image protocols, offering AI solutions specifically for MRI and PET imaging. Their flagship products, SubtleMR™ and SubtlePET™, are designed to reduce image noise and enhance sharpness, with SubtleMR™ targeting the entire body and head MRI, and SubtlePET™ improving low count PET exams conducted in up to 25% of the original scan time. These solutions can increase workflow efficiency, allowing more patients to be scanned per day and reducing wait times, while also extending the life of existing scanners by virtually upgrading them with the latest technology. Subtle Medical has achieved exponential international growth, doubling its business in the last 12 months, and its products are in commercial use in multiple hospitals and imaging centers worldwide. Both SubtleMR™ and SubtlePET™ are FDA-cleared and CE-marked. The company has raised over $45 million in funding and its technology is deployed in over 400 sites worldwide. SubtleMR™ 2.0 can be used for 99% of all MRI procedures, and SubtlePET™ 2.0 has expanded coverage for Prostate (PSMA) and Neuroendocrine tumor targeting agents. SubtleGAD™ aims to reduce gadolinium dose by 90% during contrast-enhanced MRI exams, and SubtleSYNTH™ uses deep learning to synthesize MR imaging contrast from already acquired contrasts, enabling shorter protocols. Subtle Medical has partnerships with leading pharmaceutical manufacturers and imaging equipment manufacturers, and its AI-powered software solutions are compatible with any brand of MRI or PET scanner. SubtleALLY™ includes features like image quality checks, automatic labeling, perfect image reformats, and a performance insights dashboard. The company has received multiple awards, including the Nvidia Inception Award for Top Healthcare+AI startup globally. SubtlePET™ and SubtleMR™ software solutions fit seamlessly into existing workflows, processing images within seconds.